News | August 07, 2012

Elekta and Brainlab Collaborate to Increase Accuracy and Comfort of Radiosurgery Treatments

Elekta and Brainlab Collaborate to Increase Accuracy and Comfort of Radiosurgery Treatments

August 7, 2012 —Brainlab and Elekta have announced the first installation of an Elekta linear accelerator (linac) equipped with the ExacTrac patient positioning system by Brainlab; a strategy to make radiosurgery treatments for cancer patients more accurate and comfortable. ExacTrac is planned to be integrated with a total of two Elekta linacs at Fortis Memorial Research Institute in Gurgaon, India.

"ExacTrac is a highly accurate, intuitive and fast IGRT (image-guided radiation therapy) system and, in combination with our advanced Elekta treatment system, gives us the opportunity to maximize the benefits of both systems for our patients," said Dr. Ashok V. Chordiya, zonal director, Fortis Memorial Research Institute, Gurgaon.

With more than 500 installations worldwide, ExacTrac is a field-proven system for supporting sub-millimetric patient positioning for patients with tumors anywhere in the brain and body. The system offers a valuable solution, known as frameless radiosurgery. ExacTrac helps to reduce errors within the treatment process and potentially maximize overall accuracy.

"In our search to advance the accessibility to high precision treatment alternatives that are less invasive, we required collaboration with an equally dedicated partner," said Thomas Kraft, president RoW/Japan, Brainlab. "In Elekta, we found such a partner, and one with a highly regarded, advanced treatment platform. Together we will continue to strive for optimal efficiency, integrated workflow and improved patient care."

"We believe that technology should be based on open interfaces and industry standards, since hospitals use different kinds of technical solutions. ExacTrac will give customers the freedom to choose a solution that best meets their unique workflow and patient care needs. The stereotactic workflow between both systems allows an accurate and fast workflow for patient positioning,” added Bill Yaeger, executive vice president of Elekta Oncology.

Fortis Healthcare Ltd., with an asset base spanning ten countries, is an integrated healthcare provider in the Pan Asia-Pacific region.

For more information: www.brainlab.com, www.elekta.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation